BioPro Recalls 147 Metal and Ceramic Femoral Heads Over Sterility Packaging Issue
BioPro recalled 147 femoral head components distributed in the US. The devices cover metal cobalt chromium and ceramic heads in sizes 22, 28, 32, 36 and 40 millimeters. The recall cites a packaging defect that could compromise the sterile barrier. If implanted, the loss of sterility could pose infection risk. Hospitals and surgeons should follow BioPro recall instructions immediately.
Quick Facts at a Glance
Recall Date
September 9, 2025
Hazard Level
HIGH
Brand
BioPro
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL, PREGNANT
Hazard Information
Potential packaging issue that could compromise the sterile barrier. Defect may result in loss of sterility of the device, presenting potential risk of infection if device is implanted.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact BioPro, Inc. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
BioPro femoral head components are used in hip replacement procedures. They are available in metal cobalt chromium and ceramic variants and come in multiple sizes to fit patient anatomy.
Why This Is Dangerous
A packaging defect could allow the sterile barrier to be compromised, risking infection if implanted.
Industry Context
This recall is not described as part of a broader industry pattern in the notice.
Real-World Impact
Hospitals and surgical teams must verify sterile packaging integrity. Potential infection risk could prompt reoperations or delays in treatment.
Practical Guidance
How to identify if yours is affected
Review recall notice for part IDs and sizes
Cross-check hospital inventory or supply chain records
Consult surgical teams to determine if any affected parts were used
Where to find product info
Part IDs and distribution details are in the recall listing and FDA enforcement report
What timeline to expect
Replacement and refund timelines are determined by BioPro; refer to the recall notice for next steps
If the manufacturer is unresponsive
Escalate to hospital supply chain management
Document all communications with BioPro
File a consumer safety complaint with the FDA if manufacturer guidance stalls
How to prevent similar issues
Request supplier verification of sterile packaging integrity for hip prosthesis components
Adopt strict receiving inspection procedures for implants
Verify lot numbers and date codes before implantation
Documentation advice
Keep copies of the recall notice, supplier communications, and surgical records related to implants
Product Details
Brand: BioPro. Product: Femoral Head components (Metal 22, 28, 32, 36, 40; cobalt chromium and ceramic). Part IDs include 18593 through 19135 with multiple ±/+ size variants. Quantity: 147 total units. Distribution: US Domestic to Texas and Michigan. Date recalled: 2025-09-09. Date reported: 2025-10-22.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
147 total units recalled
Sizes include 22, 28, 32, 36, 40 mm
Metal cobalt chromium and ceramic head variants
Distribution limited to Texas and Michigan in the US
Recall date 2025-09-09; report date 2025-10-22
High hazard level due to potential loss of sterility
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.